MHK
25
5
MCD
52
3
MAT
41
2
AMAT
33
3
FSLR
50
6
HES
49
2
ADT
12
2
AFL
34
6
STT
48
4
EA
41
3
TXT
46
4
DUK
49
4
THC
52
9
PH
60
5
SHW
42
5
TSCO
42
4
UHS
50
4
BK
60
2
CMI
49
2
PCG
59
9
MHK
25
5
MCD
52
3
MAT
41
2
AMAT
33
3
FSLR
50
6
HES
49
2
ADT
12
2
AFL
34
6
STT
48
4
EA
41
3
TXT
46
4
DUK
49
4
THC
52
9
PH
60
5
SHW
42
5
TSCO
42
4
UHS
50
4
BK
60
2
CMI
49
2
PCG
59
9
Financhill
Back

Becton Dickinson & Quote, Financials, Valuation and Earnings

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Buy
59

BDX
Becton Dickinson &

Last Price:
$227.82
Seasonality Move:
6.25%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Becton Dickinson & Price Quote

$227.82
+0.14 (+1.78%)
(Updated: December 21, 2024 at 5:16 AM ET)

Becton Dickinson & Key Stats

Buy
59
Becton Dickinson & (BDX) is a Buy
Day range:
$223.51 - $229.31
52-week range:
$218.75 - $249.89
Dividend yield:
1.71%
P/E ratio:
38.85
P/S ratio:
3.28
P/B ratio:
2.54%
Volume:
3M
Avg. volume:
2.2M
1-year change:
-5.06%
Market cap:
$65.8B
Revenue:
$20.2B
EPS:
$5.94

How Much Does Becton Dickinson & Make?

Data Unavailable

Is Becton Dickinson & Growing As A Company?

Data Unavailable

Becton Dickinson & Stock Price Performance

What Is Becton Dickinson & 52-Week High & Low?

Becton Dickinson & Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Becton Dickinson &?

Data Unavailable

Is Becton Dickinson & Cash Flow Positive?

Data Unavailable

Becton Dickinson & Return On Invested Capital

Data Unavailable

Becton Dickinson & Earnings Date & Stock Price

Becton Dickinson & Competitors

  • Who Are Becton Dickinson &'s Competitors?
    Below is a list of companies who compete with Becton Dickinson & or are related in some way:
    • Abbott Laboratories (ABT)
    • Baxter International Inc (BAX)
    • Boston Scientific Corp (BSX)
    • Merit Medical Systems Inc (MMSI)
    • ResMed Inc (RMD)

Becton Dickinson & Dividend Yield

Data Unavailable

Becton Dickinson & Analyst Estimates

YoY Growth Past Surprise
EPS: 291.89% 1.12%
Revenue: 6.88% 1.06%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable